Statistics for Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-a as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population.
Total visits
views | |
---|---|
Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-a as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population. | 20 |
Total visits per month
views | |
---|---|
marzo 2024 | 0 |
abril 2024 | 2 |
mayo 2024 | 1 |
junio 2024 | 0 |
julio 2024 | 0 |
agosto 2024 | 0 |
septiembre 2024 | 0 |
File Visits
views | |
---|---|
PIIS0923753419399880.pdf | 14 |